方法：前瞻性研究。选取2019-06/2020-12我院白内障术后干眼患者80例，采用随机数字表法将其分为对照组和观察组，每组各40例。对照组采用玻璃酸钠滴眼液治疗，观察组采用养血润目方联合玻璃酸钠滴眼液治疗。比较两组患者的眼表综合分析仪指标水平、角膜荧光素染色(FL)评分。

结果：治疗后，两组第1次泪膜破裂时间(NIBUTf)、平均泪膜破裂时间(NIBUTav)、泪河高度(LTMH)水平明显高于治疗前(均P<0.01)，且观察组明显高于对照组(均P<0.05)； 治疗后，两组结膜充血评分、睑板腺缺失评分、FL评分明显低于治疗前(均P<0.01)，且观察组明显低于对照组(均P<0.01)； 两组患者治疗期间均未出现明显不良反应。

结论：通过眼表综合分析仪评价分析，显示养血润目方联合玻璃酸钠用于白内障术后干眼治疗可有效改善患者眼表功能，且具有良好的安全性。

METHODS: Totally 80 patients with dry eye after cataract surgery in our hospital from June 2019 to December 2020 were selected and divided into control group and observation group by random number table method, 40 cases in each group. The control group was treated with sodium hyaluronate eye drops, and the observation group was treated with Yangxue Runmu formula combined with sodium hyaluronate eye drops. The index levels of ocular surface analyzer and fluorescein staining(FL)score were compared between the two groups.

RESULTS: After treatment, the wet length of tear film, first non-invasive tear break-up time(NIBUTf), average non-invasive tear break-up time(NIBUTav)and tear meniscus height(LTMH)in the two groups were markedly higher than those before treatment(all P<0.01), and the observation group were markedly higher than those in the control group(P<0.05); after treatment, the conjunctival hyperemia score, meibomian gland loss score, FL score in the two groups were markedly lower than those before treatment(all P<0.01), and the observation group were markedly lower than those in the control group(all P<0.01); there were no obvious adverse reactions in the two groups.

CONCLUSION: Through the evaluation and analysis of ocular surface analyzer, Yangxue Runmu formula combined with sodium hyaluronate can effectively improve the ocular surface function of patients after cataract surgery, and has good safety.